<DOC>
	<DOCNO>NCT01876459</DOCNO>
	<brief_summary>Patients memory disorder experience different trend difficult predict . Moreover , distinction Lewy body disease Alzheimer 's disease easy diseases present similar symptom . Nowadays , routine examination exist improve diagnosis specific enough one two pathology . Lewy body disease characterize presence particular structure patient 's brain , call `` Lewy body '' , compose protein call `` alpha-synuclein '' . The aim study measure rate alpha-synuclein cerebrospinal fluid . This measurement could allow u differentiate patient Alzheimer 's disease Lewy body disease .</brief_summary>
	<brief_title>Alpha-synuclein Cerebrospinal Fluid Differentiate Alzheimer 's Disease From Lewy Body Disease .</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Lewy Body Disease</mesh_term>
	<criteria>At least 45 year age Subject agree participate study Subject meet criterion Dubois et al. , 2007. diagnosis probable AD . Subject syndromic presentation mild cognitive impairment mild dementia Subject study partner able provide accurate information patient Subject affiliate social security scheme Patient meet AD Lewy Body disease criteria Contraindications lumbar puncture Contraindications MRI scan Subject affiliate social security scheme Subject guardianship curatorship Subject judicial protection Subject refuse participate study Subject evidence clinically relevant neurological disorder ( frontotemporal dementia , brain tumor , stroke , … ) lead persistent cognitive disorder Subject evidence clinically relevant psychiatric disorder ( schizophrenia , major depression , … ) Pregnant attempt become pregnant woman Subject 's vision audition sufficient neuropsychological test 's assessment , base investigator 's judgment .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>